Adhere+ Showcases Groundbreaking Research in Pain Management

Adhere+ Showcases Groundbreaking Research in Pain Management
Adhere+, a telehealth company aimed at enhancing patient outcomes, has announced significant advancements in the field of pain management. With the acceptance of two scientific posters at the prestigious American Society of Pain & Neuroscience (ASPN) Annual Conference, the company emphasizes its commitment to improving care through innovative technology.
These posters will highlight valuable insights based on more than 2.2 million patient-reported outcomes regarding Remote Therapeutic Monitoring (RTM) implementation. Adhere+ believes that effective implementation of RTM can lead to better care management for chronic pain, migraines, and musculoskeletal conditions. This is a significant step in understanding adherence patterns in real-world scenarios.
“We are thrilled to present our findings at the ASPN 2025 conference,” expressed Jim Breidenstein, CEO of Adhere+. “This research represents more than raw data; it illustrates the profound impact digital tools have on maintaining connections between healthcare providers and patients, ultimately enhancing health outcomes.”
Event Details and Presentation Highlights
The American Society of Pain & Neuroscience (ASPN) Annual Conference is set to take place in July. The event will serve as a gathering for professionals dedicated to advancing the field of pain and neuroscience through collaborative efforts and knowledge exchange.
Two informative presentations from Adhere+ will cover:
Remote Therapeutic Monitoring (RTM): Key Criteria for Evaluation and Implementation
Authors: Lynn Webster, MD; Scott Cashon; Jeff Huynh; Dan Cohen
Date/Time:
Friday, July 18 (10:25-10:45 am; 1:50-2:20 pm)
Saturday, July 19 (9:40-10:00 am; 2:25-2:55 pm)
Multi-Specialty RTM Outcomes: A Preview of 2.2M+ ePROs from a National Observational Cohort
Authors: Lynn Webster, MD; Scott Cashon; Jeff Huynh; Dan Cohen
Date/Time:
Friday, July 18 (10:25-10:45 am; 1:50-2:20 pm)
Saturday, July 19 (9:40-10:00 am; 2:25-2:55 pm)
About Adhere+
Adhere+ is revolutionizing the way patients engage with their chronic care treatment. This medical treatment compliance platform supports various health conditions, including pain management and substance use disorders. With a clinically validated approach backed by multiple peer-reviewed clinical trials, Adhere+ provides a user-friendly digital platform for physicians. Their platform empowers providers with evidence-based telehealth interventions tailored to improve patient adherence and healthcare outcomes while reducing associated costs.
Connect with Us
If you're interested in learning more about Adhere+ or our research, please reach out. Our team, including Jon Nugent of Tiberend Strategic Advisors, is here to assist you. You can contact Jon at 205-566-3026.
For media inquiries, Eric Reiss is available for comprehensive information about our efforts and research. Don't hesitate to connect.
Frequently Asked Questions
What are the main focuses of Adhere+'s research presented at ASPN?
The research emphasizes Remote Therapeutic Monitoring implementation and adherence patterns in chronic pain and related conditions.
Who is behind the research presentations?
The presentations feature experts including Lynn Webster, MD; Scott Cashon; Jeff Huynh; and Dan Cohen, all contributing to the findings.
How does the Adhere+ platform support patient care?
The platform enhances patient care through technology that monitors treatment adherence, leading to improved health outcomes.
When will the ASPN Annual Conference occur?
The conference is scheduled for July 17–20, with Adhere+'s presentations taking place on July 18 and 19.
How can one contact Adhere+ for inquiries?
For inquiries, you can reach Jon Nugent or Eric Reiss from Tiberend Strategic Advisors for further information.
About The Author
Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.